BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kim DY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Shin SW, Choo SW, Do YS, Rhee JC. Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolization. World J Gastroenterol 2006; 12(43): 6992-6997 [PMID: 17109521 DOI: 10.3748/wjg.v12.i43.6992]
URL: https://www.wjgnet.com/1948-5182/full/v12/i43/6992.htm
Number Citing Articles
1
Tengfei Si, Yongjun Chen, Di Ma, Xiaoyong Gong, Ruoyu Guan, Boyong Shen, Chenghong Peng. Transarterial chemoembolization prior to liver transplantation for patients with hepatocellular carcinoma: A meta‐analysisJournal of Gastroenterology and Hepatology 2017; 32(7): 1286 doi: 10.1111/jgh.13727
2
Antoine Bouchard-Fortier, Réal Lapointe, Pierre Perreault, Louis Bouchard, Gilles Pomier-Layrargues. Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma as a Bridge to Liver Transplantation: A Retrospective StudyInternational Journal of Hepatology 2011; 2011: 1 doi: 10.4061/2011/974514
3
Ashwini Arvind, Karim Seif El Dahan, Riya Malhotra, Darine Daher, Nicole E. Rich, Madhukar S. Patel, Lisa B. VanWagner, Sarah R. Lieber, Thomas G. Cotter, Jeremy Louissaint, Arjmand R. Mufti, Laura Kulik, Anjana Pillai, Neehar D. Parikh, Amit G. Singal. Association between bridging therapy and posttransplant outcomes in patients with HCC within Milan criteria: A systematic review and meta-analysisLiver Transplantation 2024;  doi: 10.1097/LVT.0000000000000357
4
Laura Kulik, Julie K. Heimbach, Feras Zaiem, Jehad Almasri, Larry J Prokop, Zhen Wang, M. Hassan Murad, Khaled Mohammed. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta‐analysisHepatology 2018; 67(1): 381 doi: 10.1002/hep.29485
5
Hai-Lin Li, Wen-Bin Ji, Rui Zhao, Wei-Dong Duan, Yong-Wei Chen, Xian-Qiang Wang, Qiang Yu, Ying Luo, Jia-Hong Dong. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: Retrospective analysisWorld Journal of Gastroenterology 2015; 21(12): 3599-3606 doi: 10.3748/wjg.v21.i12.3599
6
Joana Espírito Santo, Ana Ladeirinha, Ana Alarcão, Eugeniu Strelet, Marco Reis, Rui Santos, Lina Carvalho. Preoperative Locoregional Therapy May Relate with Stemness and Distinct Transitions Between Epithelial and Mesenchymal States in Hepatocellular CarcinomaJournal of Clinical and Experimental Hepatology 2024; 14(1): 101268 doi: 10.1016/j.jceh.2023.08.004
7
Kyung Jae Cho. Yamada' s Textbook of Gastroenterology2015; : 2886 doi: 10.1002/9781118512074.ch151
8
Adnan Said, Michael Einstein, Michael R Lucey. Liver transplantation: an update 2007Current Opinion in Gastroenterology 2007; 23(3): 292 doi: 10.1097/MOG.0b013e3280f9df41
9
Hye Ryun KIM, Seong Ha CHEON, Sun Young RHA, Soohyeon LEE, Kwang‐Hyub HAN, Chae Yoon CHON, Jong Doo LEE, Jin Sil SUNG, Hyun Cheol CHUNG. Treatment of recurrent hepatocellular carcinoma after liver transplantationAsia-Pacific Journal of Clinical Oncology 2011; 7(3): 258 doi: 10.1111/j.1743-7563.2011.01425.x
10
S.E. Wu, H.W. Charles, J.S. Park, A.S. Goldenberg, A.R. Deipolyi. Obesity conveys poor outcome in patients with hepatocellular carcinoma treated by transarterial chemoembolizationDiagnostic and Interventional Imaging 2017; 98(1): 37 doi: 10.1016/j.diii.2016.06.002
11
Luckshi Rajendran, Carla F. Murillo Perez, Tommy Ivanics, Marco P.A.W. Claasen, Bettina E. Hansen, David Wallace, Peter D. Yoon, Gonzalo Sapisochin. Outcomes of liver transplantation in non-alcoholic steatohepatitis (NASH) versus non-NASH associated hepatocellular carcinomaHPB 2023; 25(5): 556 doi: 10.1016/j.hpb.2023.01.019
12
Mohamed Kohla, Richard Shaw, Garret Hisatak, Robert Osorio, Maurizio Bonacini. Do Tumor Characteristics and Pre-Transplant Locoregional Therapy Predict Survival after OLT in Patients with Hepatocellular Carcinoma?International Journal of Clinical Medicine 2013; 4(12): 25 doi: 10.4236/ijcm.2013.412A1006
13
Daniel A. Butcher, Kelli J. Brandis, Haolu Wang, Liam Spannenburg, Kim R. Bridle, Darrell HG. Crawford, Xiaowen Liang. Long-term survival and postoperative complications of pre-liver transplantation transarterial chemoembolisation in hepatocellular carcinoma: A systematic review and meta-analysisEuropean Journal of Surgical Oncology 2022; 48(3): 621 doi: 10.1016/j.ejso.2021.09.017
14
Gaetano Bertino, Annalisa Ardiri, Michele Malaguarnera, Giulia Malaguarnera, Nicoletta Bertino, Giuseppe Stefano Calvagno. Hepatocellualar Carcinoma Serum MarkersSeminars in Oncology 2012; 39(4): 410 doi: 10.1053/j.seminoncol.2012.05.001
15
Jin‐Ping Lai, Andrew Conley, Beatrice S Knudsen, Maha Guindi. Hypoxia after transarterial chemoembolization may trigger a progenitor cell phenotype in hepatocellular carcinomaHistopathology 2015; 67(4): 442 doi: 10.1111/his.12623
16
Experimental and Clinical Transplantation 2018;  doi: 10.6002/ect.2018.0017
17
Shailesh Sable, Vinay Kumaran. GI Surgery AnnualGI Surgery Annual 2019; 25: 191 doi: 10.1007/978-981-13-3227-2_8
18
Chikako Zen, Yoh Zen, Ragai R. Mitry, Denis Corbeil, Jana Karbanová, John O'Grady, John Karani, Pauline Kane, Nigel Heaton, Bernard C. Portmann, Alberto Quaglia. Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantationLiver Transplantation 2011; 17(8): 943 doi: 10.1002/lt.22314
19
Kichang Han, Jin Hyoung Kim. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging systemWorld Journal of Gastroenterology 2015; 21(36): 10327-10335 doi: 10.3748/wjg.v21.i36.10327
20
Constantine Frangakis, Jean-Francois Geschwind, Daniel Kim, Yong Chen, Ayman Koteish, Kelvin Hong, Eleni Liapi, Christos S. Georgiades. Chemoembolization Decreases Drop-Off Risk of Hepatocellular Carcinoma Patients on the Liver Transplant ListCardioVascular and Interventional Radiology 2011; 34(6): 1254 doi: 10.1007/s00270-010-0077-7